TUESDAY, March 18, 2025 (HealthDay News) — The U.S. Department of Veterans Affairs (VA) has announced it will no longer provide hormone therapy to veterans newly diagnosed with gender dysphoria. The decision follows an executive order from President Donald Trump that directs federal agencies to recognize only two sexes, maleContinue Reading
TUESDAY, March 18, 2025 (HealthDay News) — Gender-affirming hormone therapy may not only help transgender and nonbinary individuals physically — it could also improve their mental health, new research suggests. A study published March 17 in JAMA Network Open found that transgender, nonbinary and gender-diverse people who were prescribed hormoneContinue Reading
TUESDAY, March 18, 2025 (HealthDay News) — Other people could be having problems with the same insulin pump, dental implant or glucose monitor that you use — and you might not find out in a timely manner. That’s because medical device manufacturers frequently fail to promptly report side effects causedContinue Reading
THURSDAY, March 6, 2025 (HealthDay News) — Hot flashes, night sweats and other symptoms of a difficult menopause could be early warning flags for dementia, a new study suggests. Women who exhibit more menopause symptoms are more likely to develop early signs of dementia like decreased mental function and mildContinue Reading
THURSDAY, Feb. 27, 2025 (HealthDay News) — Average people are right to be worried about PFAS “forever chemicals” being found in the food and water supply, an internationally renowned leader in children’s environmental health says. “We’re not overreacting, and we need to take it even more seriously in the formContinue Reading
Merilog administered subcutaneously five to 10 minutes before mealtime helps improve glycemic controlContinue Reading
FRIDAY, Jan. 17, 2025 (HealthDay News) — Artificial intelligence might be able to more quickly and affordably identify menopausal women who are having problems with memory or cognition. AI effectively identified women with severe subjective cognitive decline (SCD), or self-perceived confusion or memory problems, researchers report in a new studyContinue Reading
TUESDAY, Dec. 31, 2024 (HealthDay News) — A woman’s binge drinking might be related to her hormones. The female hormone estrogen appears to promote binge drinking in women, a new mouse study published recently in the journal Nature Communications shows. Specifically, estrogen causes women to “pre-game,” or consume large quantitiesContinue Reading
MONDAY, Nov. 25, 2024 (HealthDay News) — New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old age — bone loss. Levothyroxine is a synthetic hormone often prescribed to treat hypothyroidism. People with the condition don’t make enough thyroxineContinue Reading
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — Weekly insulin shots can help control both type 1 and type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been designed to require injections only once aContinue Reading
SATURDAY, Aug. 31, 2024 (HealthDay News) — Insulin can be a critical part of managing diabetes, but patients may not know all of the ins and outs of using the medication effectively. Luckily, the American Diabetes Association (ADA) has plenty of information and tips on using insulin. First, there areContinue Reading
TUESDAY, July 16, 2024 (HealthDay News) — Hormone therapy for breast cancer might reduce a woman’s later risk of dementia and Alzheimer’s disease, a new study finds. Overall, hormone therapy is associated with a 7% lower risk of developing Alzheimer’s or a related dementia later in life, according to findingsContinue Reading
WEDNESDAY, June 26, 2024 (HealthDay News) — The stress hormone cortisol appears to play a role in tough-to-treat type 2 diabetes, a new study finds. About 1 in 4 people (24%) with tough-to-treat type 2 diabetes have elevated cortisol levels, researchers found. “These results are significant as they highlight aContinue Reading
MONDAY, June 24, 2024 (HealthDay News) — Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows. Patients using inhaled insulin (Afrezza) plus long-lasting insulin degludec injections had better control over their blood sugar than those assignedContinue Reading